Coral Laboratories Ltd.
Coral Laboratories
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.52 Cr.
| EX-Date | Purpose |
|---|---|
| 27 05 2021 | Inter alia, to consider and approve : 1. To appoint Statutory Auditor of the Company subject to the approval by the shareholders of the Company in the ensuing Annual General Meeting. 2. To appoint Internal Auditor 3. To appoint Cost Auditor 4. To appoint Secretarial Auditor 5. To recommend appointment of Additional Independent Director. 6. Any other business with the permission of chairman. |
| 28 06 2021 | Audited Results |
| 13 08 2021 | Quarterly Results |
| 03 09 2021 | Inter alia, for the following business (es): 1. To recommend appointment of Additional Director from the date of allotment of DIN by MCA. |
| 27 09 2021 | Inter alia, to consider and approve : 1. Cost Audit Report in Form CRA -3 for the Financial Year 2020-2021. 2.To take note of Resignation of Mrs. Purvi Doshi Non-Executive Director of the Company. 3.Any other business with the permission of chairman. |
| 12 11 2021 | Quarterly Results |
| 11 02 2022 | Quarterly Results |
| 08 03 2022 | Inter alia, to consider the following business (es): 1. To take note of Resignation of Mr. Sanket Mehta Independent Director of the Company. 2. Reconstitution of Committees. 3. Any other business with the permission of chairman. |
| 27 05 2022 | Audited Results |
| 15 07 2022 | Inter alia, for the following business (es): 1. To appoint Internal Auditor 2. To appoint Cost Auditor 3. Any other business with the permission of chairman |
| 12 08 2022 | Quarterly Results & Inter alia, to consider: 2. The Directors Report for the Financial Year Ended March 31, 2022. 3. To fix date, time for convening the 40th Annual General Meeting and to approve the Notice of Annual General Meeting. 4. To appoint Cost Auditor for F.Y. 2022-2023. 5. Any other business with the permission of chairman. |
| 26 09 2022 | General Purpose |
| 11 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 23 05 2023 | Audited Results & Inter alia, to consider and approve:- 1.To appoint Secretarial Auditor for F.Y. 2023-2024. 2.To appoint Cost Auditor for F.Y. 2023-2024. 3.To appoint Internal Auditor for F.Y. 2023-2024. 4.To recommend the re-appointment of Girish M Dhameja as the Whole Time Director of the Company and fix his remuneration subject to approval of members at the ensuing AGM. 5.Any other business with the permission of chairman. |
| 11 07 2023 | Inter alia, to consider and approve :- 1. date, time for convening the 41st Annual General Meeting and to approve the Notice of Annual General Meeting. 2. Shifting of the Registered office from Vadodara, Gujarat to Mumbai, Maharashtra subject to approval of Shareholders in ensuing Annual General Meeting. 3. alteration of Memorandum of Association (MOA) of the company. 4. The reappointment of Mr. Saurabh Shah (DIN 08451204) as an Independent Director of the Company for a second term of five consecutive years. 5. To consider and approve maximum overall limit for payment of remuneration to Directors other than Whole Time Director and Managing Director subject to approvalof shareholders in ensuing Annual General Meeting. 6. Any other business with the permission of chairman. |
| 12 08 2023 | Quarterly Results |
| 26 09 2023 | inter alia, for the following business (es): 1. To approve Cost Audit Report in Form CRA -3 for the Financial Year 2022-2023. 2. Any other business with the permission of chairman. |
| 09 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 08 03 2024 | Inter alia, to consider and approve the following business (es): 1. To appoint Company Secretary and Compliance Officer of the company; 2. Any other business with the permission of chairman. |
| 24 09 2024 | Inter alia, to consider and approve:- 1. To approve Cost Audit Report in Form CRA -3 for the Financial Year 2023-2024. 2. Any other business with the permission of chairman. Thanking You. |
| 14 11 2024 | Quarterly Results |
| 13 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results & Final Dividend |
| 13 08 2025 | A.G.M. &Quarterly Results |
| 25 09 2025 | Inter alia, to consider and approved the following business (es): 1. To approve Cost Audit Report in Form CRA -3 for the Financial Year 2024-2025. 2. Any other business with the permission of chairman. |
| 14 11 2025 | Quarterly Results |
| 13 02 2026 | Quarterly Results |
No News data available
